Baricitinib in Older Adults With COVID-19 Pneumonia Baricitinib in Older Adults With COVID-19 Pneumonia

This study suggests that baricitinib, a Janus kinase inhibitor, is effective in reducing mortality in older adults with moderate-to-severe COVID-19 pneumonia.Journal of the American Geriatrics Society
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news